These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1540 related articles for article (PubMed ID: 23360966)

  • 21. A guide to genome engineering with programmable nucleases.
    Kim H; Kim JS
    Nat Rev Genet; 2014 May; 15(5):321-34. PubMed ID: 24690881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.
    Hou Z; Zhang Y; Propson NE; Howden SE; Chu LF; Sontheimer EJ; Thomson JA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15644-9. PubMed ID: 23940360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.
    Cebrian-Serrano A; Davies B
    Mamm Genome; 2017 Aug; 28(7-8):247-261. PubMed ID: 28634692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations.
    Ramakrishna S; Cho SW; Kim S; Song M; Gopalappa R; Kim JS; Kim H
    Nat Commun; 2014 Feb; 5():3378. PubMed ID: 24569644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome Engineering.
    Aouida M; Eid A; Ali Z; Cradick T; Lee C; Deshmukh H; Atef A; AbuSamra D; Gadhoum SZ; Merzaban J; Bao G; Mahfouz M
    PLoS One; 2015; 10(7):e0133373. PubMed ID: 26225561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing.
    Bolukbasi MF; Liu P; Luk K; Kwok SF; Gupta A; Amrani N; Sontheimer EJ; Zhu LJ; Wolfe SA
    Nat Commun; 2018 Nov; 9(1):4856. PubMed ID: 30451839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
    Stephenson AA; Raper AT; Suo Z
    J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells.
    Xie H; Tang L; He X; Liu X; Zhou C; Liu J; Ge X; Li J; Liu C; Zhao J; Qu J; Song Z; Gu F
    Biotechnol J; 2018 Apr; 13(4):e1700561. PubMed ID: 29247600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of Cas9 as an RNA-programmed RNA-binding protein.
    Nelles DA; Fang MY; Aigner S; Yeo GW
    Bioessays; 2015 Jul; 37(7):732-9. PubMed ID: 25880497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotyping with CRISPR-Cas-derived RNA-guided endonucleases.
    Kim JM; Kim D; Kim S; Kim JS
    Nat Commun; 2014; 5():3157. PubMed ID: 24445736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications.
    Friedland AE; Baral R; Singhal P; Loveluck K; Shen S; Sanchez M; Marco E; Gotta GM; Maeder ML; Kennedy EM; Kornepati AV; Sousa A; Collins MA; Jayaram H; Cullen BR; Bumcrot D
    Genome Biol; 2015 Nov; 16():257. PubMed ID: 26596280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.
    Stella S; Alcón P; Montoya G
    Nat Struct Mol Biol; 2017 Nov; 24(11):882-892. PubMed ID: 29035385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA targeting specificity of RNA-guided Cas9 nucleases.
    Hsu PD; Scott DA; Weinstein JA; Ran FA; Konermann S; Agarwala V; Li Y; Fine EJ; Wu X; Shalem O; Cradick TJ; Marraffini LA; Bao G; Zhang F
    Nat Biotechnol; 2013 Sep; 31(9):827-32. PubMed ID: 23873081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing the natural diversity and in vitro evolution of Cas9 to expand the genome editing toolbox.
    Karvelis T; Gasiunas G; Siksnys V
    Curr Opin Microbiol; 2017 Jun; 37():88-94. PubMed ID: 28645099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
    Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
    Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of dCas9 target search in
    Jones DL; Leroy P; Unoson C; Fange D; Ćurić V; Lawson MJ; Elf J
    Science; 2017 Sep; 357(6358):1420-1424. PubMed ID: 28963258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome editing in human stem cells.
    Byrne SM; Mali P; Church GM
    Methods Enzymol; 2014; 546():119-38. PubMed ID: 25398338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an Efficient Genome Editing Method by CRISPR/Cas9 in a Fish Cell Line.
    Dehler CE; Boudinot P; Martin SA; Collet B
    Mar Biotechnol (NY); 2016 Aug; 18(4):449-52. PubMed ID: 27236514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cas9 as a versatile tool for engineering biology.
    Mali P; Esvelt KM; Church GM
    Nat Methods; 2013 Oct; 10(10):957-63. PubMed ID: 24076990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of CRISPR-Cas9 genome interrogation in living cells.
    Knight SC; Xie L; Deng W; Guglielmi B; Witkowsky LB; Bosanac L; Zhang ET; El Beheiry M; Masson JB; Dahan M; Liu Z; Doudna JA; Tjian R
    Science; 2015 Nov; 350(6262):823-6. PubMed ID: 26564855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.